Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alzheimer's disease
Alzheimer's disease
Neurotrope stock tumbles again on Alzheimer's data
BioPharma Dive
Thu, 07/20/17 - 11:14 am
Neurotrope BioScience
Alzheimer's disease
New data from Alzheon shows long-term benefit for Alzheimer's
BioPharma Dive
Tue, 07/18/17 - 11:33 am
Alzheon
Alzheimer's disease
ALZ-801
5 trends shaping Alzheimer's drug development
BioPharma Dive
Tue, 07/18/17 - 09:23 am
Alzheimer's disease
drug development
Big Pharma VCs jump in to back a $63M mission to tackle a genetic driver of Alzheimer’s
Endpoints
Fri, 07/14/17 - 08:12 am
Big Pharma
venture capital
Alzheimer's disease
Alzheon says data backs potential of Alzheimer's candidate
PM Live
Fri, 06/23/17 - 03:34 pm
Alzheon
Alzheimer's disease
tramiprosate
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?
Xconomy
Wed, 06/21/17 - 09:46 am
Alzheimer's disease
anti-amyloid
solanezumab
Eli Lilly
Biogen
aducanumab
RVT-101
Alzheimer's Affects Twice As Many People As Estimated, Says New Study
Forbes
Thu, 06/15/17 - 02:39 pm
Alzheimer's disease
In small Alzheimer’s study, hints of modest benefit from unusual drug
Stat
Mon, 05/1/17 - 11:35 am
Alzheimer's disease
Neurotrope BioScience
Bryostatin-1
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease
FOX Business
Sat, 04/22/17 - 01:12 pm
Novartis
Alzheimer's disease
A company developing a drug to treat Alzheimer's disease just got a new CEO — and the stock is jumping
Yahoo/Business Insider
Mon, 04/10/17 - 10:12 pm
Alzheimer's disease
David Hung
Pharma CEOs
Axovant Sciences
Alzheimer's $250B Cost Could Break Medicare
Forbes
Tue, 03/7/17 - 11:16 am
Alzheimer's disease
Medicare
Roche is bringing back gantenerumab from the dead, taking another stab at Alzheimer’s PhIII
Endpoints
Tue, 03/7/17 - 10:29 am
Roche
gantenerumab
Alzheimer's disease
clinical trials
Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's
Bloomberg
Thu, 03/2/17 - 10:16 am
Alzheimer's disease
drug development
Roche
Merck
Eli Lilly
Biogen
Thumped by the FDA, Accera’s attempt to do a serious Alzheimer’s PhIII ends with a flop
Endpoints
Tue, 02/28/17 - 11:14 am
FDA
Accera
Alzheimer's disease
clinical trials
Axona
medical food
Roche to start new trial of AC Immune drug against Alzheimer's
Yahoo/Reuters
Tue, 02/28/17 - 10:05 am
Roche
AC Immune
Alzheimer's disease
clinical trials
crenezumab
Merck stopping late stage study as another Alzheimer's drug fails
Yahoo/Reuters
Tue, 02/14/17 - 07:43 pm
Merck
Alzheimer's disease
verubecestat
clinical trials
Lundbeck reads last rites on another failed PhIII Alzheimer’s program
Endpoints
Wed, 02/8/17 - 09:26 am
Lundbeck
Otsuka
Alzheimer's disease
idalopirdine
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
Xtalks
Fri, 01/27/17 - 09:30 am
AbbVie
clinical trials
anti-tau antibodies
Alzheimer's disease
ABBV-8E12
Five 'Big Idea' Biotech Trends to Watch in 2017
Forbes
Wed, 12/28/16 - 09:49 am
biotech
protein targets
Alzheimer's disease
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Yahoo/Reuters
Tue, 12/20/16 - 12:29 pm
Acadia
Alzheimer's disease
pimavanserin
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »